Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis

Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis

US Patent 6458560 · Granted Oct 1, 2002

Estimated economic value: $20,285,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Self calibrating peristaltic pump with reduced fluid pulses2025
Sensor system and methods of making2025
Measurement systems and associated techniques for sensing electrical characteris2025
Sensor system and electrodes2023
Sensor system and methods2023
Sensor system and methods of making2023
Methods for raising antibodies2023
Sensor system and electrodes2022
Sensor system and electrodes2022
Isolating a target analyte from a body fluid2022
Sensor system and methods2022
Separating target analytes using alternating magnetic fields2021